Tochigi, Japan

Shigeki Seto

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 35(Granted Patents)


Location History:

  • Tochigi, JP (1998 - 2006)
  • Shimotsuga-gun, JP (2011 - 2014)
  • Nogi, JP (2014)

Company Filing History:


Years Active: 1998-2014

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Shigeki Seto: Innovator in Pharmaceutical Chemistry

Introduction

Shigeki Seto is a prominent inventor based in Tochigi, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 10 patents to his name, Seto has made remarkable advancements in the field, particularly in the development of compounds that target various medical conditions.

Latest Patents

Among his latest patents, Seto has developed spirocyclic aminoquinolones as GSK-3 inhibitors. These compounds are designed to aid in the prevention, amelioration, or treatment of diseases mediated by GSK-3 inhibitors. Another notable invention is an indole derivative and its pharmacologically acceptable salt, which serves as an agent for treating or preventing lower urinary tract symptoms (LUTS), particularly various symptoms of overactive bladders (OABs).

Career Highlights

Seto has worked with reputable companies in the pharmaceutical industry, including Kyorin Pharmaceutical Co., Ltd. and Kissei Pharmaceutical Co., Ltd. His work in these organizations has allowed him to collaborate with other talented professionals and contribute to innovative solutions in healthcare.

Collaborations

Some of his notable coworkers include Yasumichi Fukuda and Asao Tanioka, who have also played significant roles in advancing pharmaceutical research and development.

Conclusion

Shigeki Seto's contributions to pharmaceutical chemistry through his patents and collaborations highlight his importance in the field. His innovative work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…